首页> 美国卫生研究院文献>Clinical Ophthalmology (Auckland N.Z.) >An open-label one-year noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

【2h】

An open-label one-year noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

机译：一项为期一年的开放性非对照研究用于评估玻璃体内培加他尼钠在糖尿病性黄斑水肿患者中的安全性和耐受性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe purpose of this study was to evaluate the safety and tolerability of pegaptanib in patients with diabetic macular edema.

机译：背景本研究的目的是评估培加他尼在糖尿病性黄斑水肿患者中的安全性和耐受性。

著录项

期刊名称 Clinical Ophthalmology (Auckland N.Z.)
作者
Sobha Sivaprasad; Richard C Browning; Carla Starita;
展开▼
作者单位

展开▼
年(卷),期 2014(8),-1
年度 2014
页码 1565–1571
总页数 7
原文格式 PDF
正文语种
中图分类眼科学;
关键词
pegaptanib diabetic macular edema safety tolerability;

机译：培加他尼;糖尿病性黄斑水肿;安全性;耐受性;

相似文献

外文文献
中文文献
专利

1. An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema [J] . Sobha Sivaprasad, Richard C Browning, Carla Starita Clinical ophthalmology . 2014,第4期

机译：一项为期一年的开放性非对照研究，评估玻璃体内培加他尼钠在糖尿病性黄斑水肿患者中的安全性和耐受性
2. A Collaborative Retrospective Study on the Efficacy and Safety of Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema The European DME Registry Study [J] . Rosenblatt Amir, Udaondo Patricia, Cunha-Vaz Jose, Ophthalmology . 2020,第3期

机译：一种合作回顾性研究术术患者糖尿病MATEMA患者患者患有玻璃体外地塞米松植入物（Ozurdex）欧洲DME注册表研究的疗效及安全性研究
3. Prospective study to evaluate the safety of Dexamethasone Intravitreal Implant in Diabetic Macular Edema. [J] . Di Monaco Silvio, Berteramo Simona, Delle Noci Nicola, Investigative ophthalmology & visual science . 2016,第12期

机译：评价卵塞酮含有术治疗糖尿病性黄瓜水肿的植入术治疗的前瞻性研究。
4. Inter-observer Reliability and Agreement Study on Early Diagnosis of Diabetic Retinopathy and Diabetic Macular Edema Risk [C] . Manuel Emilio Gegundez-Arias, Carlos Ortega, Javier Garrido, International Conference on Bioinformatics and Biomedical Engineering . 2016

机译：糖尿病视网膜病变和黄斑水肿风险的早期诊断的观察者间可靠性和一致性研究
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Safety and Tolerability of Topical Ophthalmic Triamcinolone Acetonide-Loaded Liposomes Formulation and Evaluation of Its Biologic Activity in Patients with Diabetic Macular Edema [O] . Jose Navarro-Partida, Juan Carlos Altamirano-Vallejo, Alejandro Gonzalez-De la Rosa, 2021

机译：局部眼科脂质醇酮糖苷脂质体的安全性和耐受性糖尿病性黄斑水肿患者生物活性的制剂和评价
7. An open-label, one-year, noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema [O] . Sobha Sivaprasad, Richard Browning, Carla Starita 2014

机译：开放标签，一年，非渗透研究，以评估糖尿病患者患有糖尿病黄斑水肿患者玻璃体内PEGAPTANIB钠的安全性和耐受性

An open-label one-year noncomparative study to evaluate the safety and tolerability of intravitreal pegaptanib sodium in patients with diabetic macular edema

摘要

著录项

相似文献

相关主题

期刊订阅